News

A study by scientists at The Pirbright Institute and the Babraham Institute has detailed how immune cells in pigs lung change after influenza infection or vaccination. For protection against influenza in livestock or humans, it is important that a vaccine induces the right combination of immune…

New insights into our immune responses could pave the way for innovative treatments and vaccines. Research by Pirbright scientists, as part of an international collaboration, has informed a new paper published in the Journal of Biological Chemistry. The study shows an important section of our immune…

Researchers at Pirbright have developed a pig respiratory coronavirus (PRCV) model which will help to understand how coronaviruses cause disease and how the immune system responds to them. Human coronaviruses such as Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS…

Pirbright scientists investigate the pig’s immune response to flu and identify specific cells which are important for fighting infection and for long term protection against influenza infection. It is hoped the findings will shed more light on human response to flu and help the development of new…

To highlight the essential role women are playing in progressing crucial COVID-19 research, the Permanent Mission of Greece to the UN, the Permanent Mission of Lebanon, with the support of the Permanent Mission of the UK and UN Women, staged an online event called ‘The Hypatia Debate: Women…

In a collaborative study, with the University of Oxford, The University of Melbourne/Doherty Institute, the University of Edinburgh’s Roslin Institute, Animal and Plant Health Agency, Utrecht University and The University of Queensland, scientists at The Pirbright Institute have identified new…

The Pirbright Institute has generated the first pig antibodies against swine influenza (flu) that protect against infection and recognise the same parts of the flu virus as human antibodies. This indicates they could be used to develop and assess human antibody therapies and their delivery methods…

Studies carried out by The Pirbright Institute and the University of Oxford have shown that Oxford’s new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this…

Flu vaccine research undertaken by scientists at The Pirbright Institute has demonstrated that combining two different routes of administering flu vaccine provides pigs with better protection against disease than using only one method. The findings could inform vaccination strategies for human flu…

Effective flu vaccines are crucial for controlling disease outbreaks in pigs and reducing the threat of transmission to humans. A collaboration between The Pirbright Institute, the Animal and Plant Health Agency (APHA), the University of Edinburgh and The Jenner Institute has shown that several…

Studies undertaken at The Pirbright Institute in collaboration with Inovio Pharmaceuticals have shown that pigs can be used to assess whether influenza antibody therapies are effective, which could provide a better indication of their success in humans than small animal trials. They also…